KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic Cells

2009/09/10 by Shary N. Shelton, Mary E. Shawgo, Shawna B. Matthews +11 · 28 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Materials Science · Medicine · #Antibiotics #Biochemistry #Biology #Chemistry #Enzyme Structure and Function #Gene #Heat shock protein #Heat shock proteins research #Internal medicine #Medicine #Molecular biology #Novobiocin #Protein Structure and Dynamics #Shock (circulatory)

paper · pdf · doi:10.1124/mol.109.058545

openalex publication_date 2009/09/10 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06

Cited by

• Hsp90 Inhibition on the Western Blot: N‐Terminal Versus C‐Terminal Inhibitors in Breast Cancer
• Natural Product Inspired N‐Terminal Hsp90 Inhibitors: From Bench to Bedside?
• Heat Shock Proteins and Cancer
• Targeting the dynamic HSP90 complex in cancer. [europepmc]
• Elucidation of the Hsp90 C-terminal inhibitor binding site. [europepmc]
• Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. [europepmc]
• Novel C-terminal Hsp90 inhibitor for head and neck squamous cell cancer (HNSCC) with in vivo efficacy and improved toxicity profiles compared with standard agents. [europepmc]
• Synthesis and Evaluation of Noviose Replacements on Novobiocin that Manifest Anti-proliferative Activity. [europepmc]
• A novel C-terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells. [europepmc]
• Novobiocin analogues with second-generation noviose surrogates. [europepmc]
• Spotlight on the microbes that produce heat shock protein 90-targeting antibiotics. [europepmc]
• Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity. [europepmc]
• Identification of the plant compound geraniin as a novel Hsp90 inhibitor. [europepmc]
• Identification of a new scaffold for hsp90 C-terminal inhibition. [europepmc]
• Alternative approaches to Hsp90 modulation for the treatment of cancer. [europepmc]
• Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells. [europepmc]
• Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors. [europepmc]
• The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis. [europepmc]
• Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside? [europepmc]
• Neuroprotective effect of paeoniflorin on H 2 O 2 -induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response. [europepmc]
• Development of Noviomimetics as C-Terminal Hsp90 Inhibitors. [europepmc]
• Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects. [europepmc]
• Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors. [europepmc]
• New Opportunities for Targeting the Androgen Receptor in Prostate Cancer. [europepmc]
• Stimulation of heat shock protein 90 chaperone function through binding of a novobiocin analog KU-32. [europepmc]
• The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer. [europepmc]
• Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy. [europepmc]
• HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review). [europepmc]